Florence Releases 2021 State of Clinical Trial Technology Industry Report
Summary
"The data confirmed what we hear from the 8,000 study sites and hundreds of sponsors in over 30 countries on our network; COVID forced organizations to accelerate their technology transformation plans," said Blake Adams, VP Marketing at Florence. Key findings from the survey conducted online in late November and early December include: • 47% of sites and 36% of sponsors indicated they increased their 2020 technology budgets to reduce disruptions from COVID. "Sites and sponsors pushed it forward to deal with restricted access during COVID, but now understand and have begun to measure the long-term benefits it can have on study timelines, inspection readiness and workloads." "In keeping with our mission to advance research together, we are committed to being more than just another software vendor; we strive to be stakeholders in our customers success," said Ryan Jones, CEO and Co-Founder of Florence. Florence advances clinical trials through software for managing document and data flow between research sites and sponsors.
Classifications
AskAI Classifications
LabelsLinked Companies
